GTC Biotherapeutics (fka GTCB)

[nivasvs]

The timing really sucks. Why couldn't they wait until BIO CEO's meeting done?

Why at $0.87 ????????

After these statements non long ago??

The US market opportunity for the DIC indication is estimated to be $2 - 3 billion.

Discussions with potential partners for the commercialization and further development of ATryn® in the US have continued through the end of 2007. GTC is planning to conclude an agreement during the first quarter of 2008.